Related Experiment Video
Updated: Dec 26, 2025

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery
Published on: August 9, 2024
The evaluation of complete blood count parameters in the patients with idiopathic versus secondary cerebral venous
Mohammad Javad Gholamzadeh1,2,3, Etrat Hooshmandi2, Zahra Ghahramani4
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Complete blood count (CBC) markers like red cell distribution width (RDW) may help assess cerebral venous thrombosis (CVT) risk. Lower red blood cell (RBC) counts and hemoglobin (Hb) were linked to CVT, with distinct CBC profiles differentiating idiopathic from secondary CVT.
Area of Science:
- Neurology
- Hematology
- Medical Diagnostics
Background:
- Cerebral venous thrombosis (CVT) risk assessment lacks definitive laboratory markers.
- Existing evidence on complete blood count (CBC) parameters as CVT indicators is limited and conflicting.
Purpose of the Study:
- To investigate the association between CBC parameters and the development of CVT.
- To explore the relationship between CBC markers and specific CVT characteristics, including idiopathic (iCVT) and secondary (sCVT) forms.
Main Methods:
- A case-control study involving 295 CVT patients and 341 healthy controls.
- Analysis of CBC parameters including red cell distribution width (RDW), red blood cell (RBC) count, hemoglobin (Hb), and hematocrit.
- Logistic regression was used to identify predictors of iCVT.
Main Results:
- CVT patients exhibited higher RDW and lower RBC count, Hb, and hematocrit compared to controls.
- Idiopathic CVT (iCVT) cases showed higher RBC count, Hb, and hematocrit than secondary CVT (sCVT) cases.
- Female gender, smoking, and elevated hematocrit were associated with increased iCVT probability.
Conclusions:
- Certain CBC parameters may serve as potential biomarkers for CVT risk stratification.
- CBC profiles can potentially differentiate between iCVT and sCVT.
- Further research is warranted to elucidate the underlying pathophysiological mechanisms.
Abstract:
Background: Several laboratory markers derived from a complete blood count (CBC) have been proposed as potential indicators for assessing the risk of cerebral venous thrombosis (CVT). However, limited and conflicting evidence exists regarding this association. This study aimed to evaluate the role of CBC parameters in CVT development and their link to disease characteristics. Methods: This case-control study included patients diagnosed with CVT between March 2018 and March 2021. All participants with CVT were registered in the organized registry system at the Neurology Research Center of Shiraz University of Medical Sciences, Shiraz, Iran (CVT registry code: 9001013381). The control group consisted of age- and sex-matched individuals without systemic diseases. CBC results from the control group and the first recorded hospital CBC of the patient group were collected. Results: The study included 295 patients with CVT [49 with idiopathic CVT (iCVT) and 246 with secondary CVT (sCVT)] and 341 healthy individuals. Among the CVT group, 72.54% were women. Patients with CVT had higher red cell distribution width (RDW) and lower red blood cell (RBC) count, hemoglobin (Hb) levels, and hematocrit compared to the non-CVT group. In iCVT cases, male gender, RBC count, Hb levels, and hematocrit were notably higher compared to sCVT cases. Logistic regression analysis showed that female gender, smoking, and higher hematocrit values were associated with increased probability of iCVT. Conclusion: The study suggests that certain CBC parameters may serve as potential markers for assessing CVT risk and differentiating between iCVT and sCVT cases. Validation and further research are needed to explore the underlying mechanisms.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

